SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rebeccah A. McKibben, Sabina A. Haberlen, Wendy S. Post, Todd T. Brown, Matthew Budoff, Mallory D. Witt, Lawrence A. Kingsley, Frank J. Palella, Chloe L. Thio, Eric C. Seaberg, A Cross-sectional Study of the Association Between Chronic Hepatitis C Virus Infection and Subclinical Coronary Atherosclerosis Among Participants in the Multicenter AIDS Cohort Study, Journal of Infectious Diseases, 2016, 213, 2, 257

    CrossRef

  2. You have free access to this content2
    G. Indolfi, G. Mangone, M. Moriondo, D. Serranti, E. Bartolini, C. Azzari, M. Resti, Altered natural killer cells subsets distribution in children with hepatitis C following vertical transmission, Alimentary Pharmacology & Therapeutics, 2016, 43, 1
  3. 3
    Theodoros Voulgaris, Vassilios A. Sevastianos, Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus, Hepatitis Research and Treatment, 2016, 2016, 1

    CrossRef

  4. 4
    Salvatore Petta, Marcello Maida, Fabio Salvatore Macaluso, Marco Barbara, Anna Licata, Antonio Craxì, Calogero Cammà, Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies, Gastroenterology, 2016, 150, 1, 145

    CrossRef

  5. 5
    Vasiliki Katsi, Ioannis Felekos, Stamatios Skevofilax, Constantina Aggeli, Dimitris Tousoulis, Christodoulos Stefanadis, Ioannis Kallikazaros, Cardiovascular Disease and Hepatitis C Virus Infection, Cardiology in Review, 2015, 23, 1, 11

    CrossRef

  6. 6
    Laura Serres, Philippe Vasseur, David Tougeron, Elise Gand, Carine Chagneau-Derrode, Florian Charier, Sophie Rochd, Christine Silvain, Cardiovascular events in chronic hepatitis C, European Journal of Gastroenterology & Hepatology, 2015, 27, 11, 1286

    CrossRef

  7. 7
    Amy C. Sherman, Kenneth E. Sherman, Extrahepatic Manifestations of Hepatitis C Infection: Navigating CHASM, Current HIV/AIDS Reports, 2015, 12, 3, 353

    CrossRef

  8. 8
    Francesco Negro, Daniel Forton, Antonio Craxì, Mark S. Sulkowski, Jordan J. Feld, Michael P. Manns, Extrahepatic Morbidity and Mortality of Chronic Hepatitis C, Gastroenterology, 2015, 149, 6, 1345

    CrossRef

  9. 9
    Dalia A. Omran, Noha Hosam E.L. Din Behairy, Khaled Serag Zakaria, Mohamed Mahmoud Nabil, Karim Said, Functional and morphological myocardial changes in hepatitis C virus patients with end-stage liver disease, Scandinavian Journal of Gastroenterology, 2015, 50, 9, 1135

    CrossRef

  10. 10
    Kirat Gill, Hasmik Ghazinian, Richard Manch, Robert Gish, Hepatitis C virus as a systemic disease: reaching beyond the liver, Hepatology International, 2015,

    CrossRef

  11. 11
    Yueh-Han Hsu, Chih-Hsin Muo, Chun-Yi Liu, Wen-Chen Tsai, Chih-Cheng Hsu, Fung-Chang Sung, Chia-Hung Kao, Hepatitis C virus infection increases the risk of developing peripheral arterial disease: A 9-year population-based cohort study, Journal of Hepatology, 2015, 62, 3, 519

    CrossRef

  12. 12
    Dalia E. Desouky, Zaynab Kasemy, Alaa E. Abdel-Hamid, Mohamed S. Omar, Insulin Resistance and Prediabetes in Hepatitis C Virus Patients, The American Journal of the Medical Sciences, 2015, 350, 2, 77

    CrossRef

  13. 13
    Yueh-Han Hsu, Peir-Haur Hung, Chih-Hsin Muo, Wen-Chen Tsai, Chih-Cheng Hsu, Chia-Hung Kao, Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease, Medicine, 2015, 94, 47, e2113

    CrossRef

  14. 14
    Kerry Townsend, Eric G. Meissner, Sreetha Sidharthan, Maureen Sampson, Alan T. Remaley, Lydia Tang, Anita Kohli, Anu Osinusi, Henry Masur, Shyam Kottilil, Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration, AIDS Research and Human Retroviruses, 2015,

    CrossRef

  15. 15
    Daniel Pineda-Tenor, Juan Berenguer, María A. Jiménez-Sousa, Ana Carrero, Mónica García-Álvarez, Teresa Aldámiz-Echevarria, Pilar García-Broncano, Cristina Diez, María Guzmán-Fulgencio, Amanda Fernández-Rodríguez, Salvador Resino, rs7903146 Polymorphism atTranscription Factor 7 Like 2Gene Is Associated with Total Cholesterol and Lipoprotein Profile in HIV/Hepatitis C Virus-Coinfected Patients, AIDS Research and Human Retroviruses, 2015, 31, 3, 326

    CrossRef

  16. 16
    Kara W. Chew, Debika Bhattacharya, Kathleen A. McGinnis, Tamara B. Horwich, Chi-hong Tseng, Judith S. Currier, Adeel A. Butt, Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons, AIDS Research and Human Retroviruses, 2015, 31, 7, 718

    CrossRef

  17. 17
    Viktor V Chirikov, Fadia T Shaya, Charles D Howell, Association between interferon use and reduced metabolic and vascular complications among patients with hepatitis C, Expert Review of Gastroenterology & Hepatology, 2014, 8, 8, 973

    CrossRef

  18. 18
    Daniel Pineda-Tenor, Juan Berenguer, Pilar García-Broncano, María A. Jiménez-Sousa, Amanda Fernández-Rodríguez, Cristina Diez, Mónica García–Álvarez, Ana Carrero, Pilar Catalán, Teresa Aldámiz-Echevarria, Salvador Resino, Association of adiponectin (ADIPOQ) rs2241766 polymorphism and dyslipidemia in HIV/HCV-coinfected patients, European Journal of Clinical Investigation, 2014, 44, 5
  19. 19
    S. Petta, F. S. Macaluso, A. Craxi, Cardiovascular diseases and HCV infection: a simple association or more?, Gut, 2014, 63, 3, 369

    CrossRef

  20. 20
    Francesco Negro, Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases, Journal of Hepatology, 2014, 61, 1, S69

    CrossRef

  21. 21
    Robert J. Wong, Fasiha Kanwal, Zobair M. Younossi, Aijaz Ahmed, Hepatitis C Virus Infection and Coronary Artery Disease Risk: A Systematic Review of the Literature, Digestive Diseases and Sciences, 2014, 59, 7, 1586

    CrossRef

  22. 22
    Linda Henry, Zobair Younossi, Hepatitis: Chronic HCV infection, diabetes and liver-related outcomes, Nature Reviews Gastroenterology and Hepatology, 2014, 11, 9, 520

    CrossRef

  23. 23
    M. A. Jiménez-Sousa, J. Berenguer, A. Fernández-Rodríguez, D. Micheloud, M. Guzmán-Fulgencio, P. Miralles, D. Pineda-Tenor, M. García–Álvarez, J. C. López, T. Aldámiz-Echevarria, A. Carrero, S. Resino, IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV-coinfected patients, Journal of Viral Hepatitis, 2014, 21, 3
  24. 24
    R. Mahajan, J. Xing, S. J. Liu, K. N. Ly, A. C. Moorman, L. Rupp, F. Xu, S. D. Holmberg, S. D. Holmberg, E. H. Teshale, P. R. Spradling, A. C. Moorman, S. C. Gordon, D. R. Nerenz, M. Lu, L. Lamerato, L. B. Rupp, N. Akkerman, N. Oja-Tebbe, C. M. Cogan, D. Larkin, J. A. Boscarino, Z. S. Daar, J. B. Leader, R. E. Smith, C. C. Nakasato, V. Vijayadeva, K. E. Sylva, J. V. Parker, M. M. Schmidt, M. A. Schmidt, J. L. Donald, E. M. Keast, Mortality Among Persons in Care With Hepatitis C Virus Infection: The Chronic Hepatitis Cohort Study (CHeCS), 2006-2010, Clinical Infectious Diseases, 2014, 58, 8, 1055

    CrossRef

  25. 25
    Pilar García-Broncano, Juan Berenguer, Amanda Fernández-Rodríguez, Daniel Pineda-Tenor, María Ángeles Jiménez-Sousa, Mónica García–Alvarez, Pilar Miralles, Teresa Aldámiz-Echevarria, Juan Carlos López, Dariela Micheloud, Salvador Resino, PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study, Journal of Translational Medicine, 2014, 12, 1

    CrossRef

  26. 26
    Constance E. Ruhl, Andy Menke, Catherine C. Cowie, James E. Everhart, Relationship of hepatitis C virus infection with diabetes in the U.S. population, Hepatology, 2014, 60, 4
  27. You have free access to this content27
    J. Ampuero, M. Romero-Gómez, K. R. Reddy, Review article: HCV genotype 3 – the new treatment challenge, Alimentary Pharmacology & Therapeutics, 2014, 39, 7
  28. 28
    Daniel Pineda-Tenor, Dariela Micheloud, Juan Berenguer, María A. Jiménez-Sousa, Amanda Fernández-Rodríguez, Pilar García-Broncano, María Guzmán-Fulgencio, Cristina Diez, José M. Bellón, Ana Carrero, Teresa Aldámiz-Echevarria, Mónica García-Álvarez, Salvador Resino, SLC30A8 rs13266634 polymorphism is related to a favorable cardiometabolic lipid profile in HIV/hepatitis C virus-coinfected patients, AIDS, 2014, 28, 9, 1325

    CrossRef

  29. You have free access to this content29
    Z. M. Younossi, F. Kanwal, S. Saab, K. A. Brown, H. B. El-Serag, W. R. Kim, A. Ahmed, M. Kugelmas, S. C. Gordon, The impact of hepatitis C burden: an evidence-based approach, Alimentary Pharmacology & Therapeutics, 2014, 39, 5
  30. 30
    Nicolas Goossens, Francesco Negro, The Impact of Obesity and Metabolic Syndrome on Chronic Hepatitis C, Clinics in Liver Disease, 2014, 18, 1, 147

    CrossRef

  31. 31
    Amr Hany Metwally, Mohamed-Adel F. Elgamal, The relation between hepatitis C virus and coronary heart disease, Medical Hypotheses, 2014, 82, 4, 505

    CrossRef

  32. 32
    Fabrizio Fabrizi, Piergiorgio Messa, Paul Martin, The Unravelled Link between Chronic Kidney Disease and Hepatitis C Infection, New Journal of Science, 2014, 2014, 1

    CrossRef

  33. 33
    Cheryl Enger, Ulla M. Forssen, Dimitri Bennett, Dickens Theodore, Sumitra Shantakumar, Andrew McAfee, Thromboembolic Events Among Patients with Hepatitis C Virus Infection and Cirrhosis: A Matched-Cohort Study, Advances in Therapy, 2014, 31, 8, 891

    CrossRef

  34. 34
    Francesco Negro, Hepatitis C in 2013: HCV causes systemic disorders that can be cured, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 2, 77

    CrossRef

  35. You have free access to this content35
    S. C. Gordon, F. M. Hamzeh, P. J. Pockros, R. S. Hoop, A. R. Buikema, E. J. Korner, N. A. Terrault, Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease, Alimentary Pharmacology & Therapeutics, 2013, 38, 7
  36. 36
    Fabio Salvatore Macaluso, Marcello Maida, Maria Giovanna Minissale, Teresa Li Vigni, Simona Attardo, Emanuele Orlando, Salvatore Petta, Metabolic Factors and Chronic Hepatitis C: A Complex Interplay, BioMed Research International, 2013, 2013, 1

    CrossRef

  37. 37
    Jerzy Jaroszewicz, Robert Flisiak, Metabolic syndrome and hepatitis C infection – brothers in arms, Liver International, 2013, 33, 8